Fig. 1 · Structure
Documents & Downloads
BMY-21502
Pyrrolidinone Derivative
BMY-21502 is a pyrrolidinone derivative that enhances memory and cognitive function. This compound demonstrates protective effects against hypoxia-induced impairments in brain activity, characterized by a decrease in delta/theta wave activity and an increase in alpha wave activity. BMY-21502 is valuable for research applications focusing on neurological disorders and cognitive enhancement.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 123259-91-6 |
| Applications | Pyrrolidinone Derivative |
| Formula | C15H19F3N4O |
| Molecular Weight | 328.33 |
| Synonyms | BMS-181168 |
| SMILES | O=C1N(CC2CCN(CC2)C3=NC(C(F)(F)F)=NC=C3)CCC1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.